APG Asset Management US’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,752
Closed -$281K 208
2024
Q4
$281K Sell
6,752
-953
-12% -$45.5K ﹤0.01% 196
2024
Q3
$493K Sell
7,705
-20,160
-72% -$1.85M ﹤0.01% 137
2024
Q2
$3.23M Sell
27,865
-13,334
-32% -$1.69M 0.02% 157
2024
Q1
$4.35M Sell
41,199
-21,456
-34% -$2.16M 0.03% 156
2023
Q4
$6.23M Buy
+62,655
New +$5.27M 0.04% 123

Other funds holding MRNA

APG Asset Management US's MRNA Position: Q1 2025 in Review

APG Asset Management US sold out of Moderna (MRNA) in Q1 2025, closing a stake of 6,752 shares — an estimated $281K sold.

APG Asset Management US first reported a position in MRNA in Q4 2023 and held it in 5 quarters. The position peaked at $6.23M in Q4 2023. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • APG Asset Management US reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • APG Asset Management US sold 6,752 Moderna shares in Q1 2025, an estimated $281K.
  • APG Asset Management US first reported a position in Moderna in Q4 2023 and held it in 5 quarters.
  • APG Asset Management US's Moderna position peaked at $6.23M in Q4 2023.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on APG Asset Management US's 13F filing for Q1 2025, filed 14 May 2025.